cell therapies

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

Patenting Antibody and Cell Therapies – What to Do and What Not to Do

By Joanna Applequist, Louise Jonshammar, Niklas Mattsson | Posted on September 28, 2020

Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is...

Read more : Patenting Antibody and Cell Therapies – What to Do and What Not to Do

Filed under: Webinars

Tags: antibodies, Biotechnology, cell therapies, EPO, Litigation, patents

Recent contributors

Ai-Leen Lim, Partner and Attorney at Law, Hong Kong SAR

Ai-Leen Lim

Partner, Attorney at Law, Group Vice President

Julia Wang, Senior Associate and Attorney at Law, Beijing, China

Julia Wang

Senior Associate, Attorney at Law

Ylva Strandberg, Counsel and AU and NZ Patent Attorney, Stockholm, Sweden

Ylva Strandberg

Counsel, AU and NZ Patent Attorney

Hongyue Li, Senior Associate and China Patent Attorney, Beijing, China

Hongyue Li

Senior Associate, China Patent Attorney

Isa Böttiger, Associate and Attorney at Law, Stockholm, Sweden

Isa Böttiger

Senior Associate, Attorney at Law

Ylva Wikmark, Counsel and European Patent Attorney, Stockholm, Sweden

Ylva Wikmark

Counsel, European Patent Attorney